Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Enantiomeric separation of vilanterol trifenatate by chiral liquid chromatography.

Guo Y, Yang Y, Peng J, Zhu X, Ji Z.

Chirality. 2019 Oct;31(10):813-817. doi: 10.1002/chir.23105. Epub 2019 Aug 8.

PMID:
31392772
2.

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system.

An Q, Zheng Y, Zhao Y, Liu T, Guo H, Zhang D, Qian W, Wang H, Guo Y, Hou S, Li J.

Drug Des Devel Ther. 2019 Mar 12;13:791-805. doi: 10.2147/DDDT.S170913. eCollection 2019.

3.

Sex Differences in Cardiovascular Risk Profile From Childhood to Midlife Between Individuals Who Did and Did Not Develop Diabetes at Follow-up: The Bogalusa Heart Study.

Du T, Fernandez C, Barshop R, Guo Y, Krousel-Wood M, Chen W, Qi L, Harville E, Mauvais-Jarvis F, Fonseca V, Bazzano L.

Diabetes Care. 2019 Apr;42(4):635-643. doi: 10.2337/dc18-2029. Epub 2019 Jan 28.

PMID:
30692238
4.

Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses.

Liu B, Guo H, Xu J, Qin T, Guo Q, Gu N, Zhang D, Qian W, Dai J, Hou S, Wang H, Guo Y.

MAbs. 2018 Feb/Mar;10(2):315-324. doi: 10.1080/19420862.2017.1409319. Epub 2017 Dec 20.

5.

Long-Term Excessive Body Weight and Adult Left Ventricular Hypertrophy Are Linked Through Later-Life Body Size and Blood Pressure: The Bogalusa Heart Study.

Zhang H, Zhang T, Li S, Guo Y, Shen W, Fernandez C, Harville E, Bazzano LA, Urbina EM, He J, Chen W.

Circ Res. 2017 May 12;120(10):1614-1621. doi: 10.1161/CIRCRESAHA.116.310421. Epub 2017 Feb 23.

6.

Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.

Pan F, Mao H, Bu F, Tong X, Li J, Zhang S, Liu X, Wang L, Wu L, Chen R, Wei H, Li B, Li C, Yang Y, Steer CJ, Zhao J, Guo Y.

Oncotarget. 2017 Jan 24;8(4):5735-5752. doi: 10.18632/oncotarget.13902.

7.

Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.

Gao J, Li W, Guo Y, Feng SS.

Nanomedicine (Lond). 2016 Dec;11(24):3261-3282. Epub 2016 Nov 17. Review.

PMID:
27854161
8.

Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer.

Chen X, Xu J, Guo Q, Wang L, Yang Y, Guo H, Gu N, Zhang D, Qian W, Hou S, Li J, Dai J, Guo Y, Wang H.

Biochem Biophys Res Commun. 2016 Nov 11;480(2):160-165. doi: 10.1016/j.bbrc.2016.10.011. Epub 2016 Oct 5.

PMID:
27720718
9.

Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients.

Mao H, Pan F, Guo H, Bu F, Xin T, Chen S, Guo Y.

Tumour Biol. 2016 Sep;37(9):12223-12230. Epub 2016 May 28.

PMID:
27235120
10.

ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.

Xu L, Tong X, Zhang S, Yin F, Li X, Wei H, Li C, Guo Y, Zhao J.

Tumour Biol. 2016 Oct;37(10):13669-13677. Epub 2016 Jul 29.

PMID:
27473084
11.

In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS.

Liu B, Guo H, Zhang J, Xue J, Yang Y, Qin T, Xu J, Guo Q, Zhang D, Qian W, Li B, Hou S, Dai J, Guo Y, Wang H.

Mol Pharm. 2016 Aug 1;13(8):2702-10. doi: 10.1021/acs.molpharmaceut.6b00280. Epub 2016 Jul 21.

PMID:
27377124
12.

Acid-induced aggregation propensity of nivolumab is dependent on the Fc.

Liu B, Guo H, Xu J, Qin T, Xu L, Zhang J, Guo Q, Zhang D, Qian W, Li B, Dai J, Hou S, Guo Y, Wang H.

MAbs. 2016 Aug-Sep;8(6):1107-17. doi: 10.1080/19420862.2016.1197443. Epub 2016 Jun 16.

13.

Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse.

Pu Y, Xu M, Liang Y, Yang K, Guo Y, Yang X, Fu YX.

Sci Transl Med. 2016 Apr 6;8(333):333ra47. doi: 10.1126/scitranslmed.aad5659.

PMID:
27053771
14.

Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells.

Li Y, Fu T, Liu T, Guo H, Guo Q, Xu J, Zhang D, Qian W, Dai J, Li B, Guo Y, Hou S, Wang H.

MAbs. 2016 Jul;8(5):951-60. doi: 10.1080/19420862.2016.1172150. Epub 2016 Apr 6.

15.

Prenatal and Postnatal Survival of Fetal Tetralogy of Fallot: A Meta-analysis of Perinatal Outcomes and Associated Genetic Disorders.

Zhao Y, Abuhamad A, Fleenor J, Guo Y, Zhang W, Cao D, Zeng S, Sinkovskaya E, Zhou Q.

J Ultrasound Med. 2016 May;35(5):905-15. doi: 10.7863/ultra.15.04055. Epub 2016 Mar 28.

PMID:
27022172
16.

A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion.

Shi X, Deng Y, Wang H, Ji G, Tan W, Jiang T, Li X, Zhao H, Xia T, Meng Y, Wang C, Yu X, Yang Y, Li B, Qin ED, Dai J, Qin CF, Guo Y.

MAbs. 2016;8(3):574-84. doi: 10.1080/19420862.2016.1148850. Epub 2016 Feb 23.

17.

Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy.

Yang Y, Guo Q, Chen X, Zhang J, Guo H, Qian W, Hou S, Dai J, Li B, Guo Y, Wang H.

MAbs. 2016;8(2):405-13. doi: 10.1080/19420862.2015.1127491.

18.

[Progress in monoclonal antibody-based immunotherapy for cancer treatment].

Guo Y.

Sheng Wu Gong Cheng Xue Bao. 2015 Jun;31(6):857-70. Review. Chinese.

PMID:
26672362
19.

Retraction Note to: Structure-based development and optimization of therapy antibody drugs against TNF╬▒.

Fu W, Wang X, Yang W, Takeda H, Hu S, Lou Z, Zhao J, Bethune AN, Guo Y.

Amino Acids. 2016 Jan;48(1):319. doi: 10.1007/s00726-015-2147-2. No abstract available.

PMID:
26650200
20.

CD20 Antibody-Conjugated Immunoliposomes for Targeted Chemotherapy of Melanoma Cancer Initiating Cells.

Song H, Su X, Yang K, Niu F, Li J, Song J, Chen H, Li B, Li W, Qian W, Cao X, Guo S, Dai J, Feng SS, Guo Y, Yin C, Gao J.

J Biomed Nanotechnol. 2015 Nov;11(11):1927-46.

PMID:
26554153

Supplemental Content

Loading ...
Support Center